» Articles » PMID: 37959328

Ten Issues for Updating in Community-Acquired Pneumonia: An Expert Review

Abstract

Community-acquired pneumonia represents the third-highest cause of mortality in industrialized countries and the first due to infection. Although guidelines for the approach to this infection model are widely implemented in international health schemes, information continually emerges that generates controversy or requires updating its management. This paper reviews the most important issues in the approach to this process, such as an aetiologic update using new molecular platforms or imaging techniques, including the diagnostic stewardship in different clinical settings. It also reviews both the Intensive Care Unit admission criteria and those of clinical stability to discharge. An update in antibiotic, in oxygen, or steroidal therapy is presented. It also analyzes the management out-of-hospital in CAP requiring hospitalization, the main factors for readmission, and an approach to therapeutic failure or rescue. Finally, the main strategies for prevention and vaccination in both immunocompetent and immunocompromised hosts are reviewed.

Citing Articles

Ten Questions on Using Lung Ultrasonography to Diagnose and Manage Pneumonia in the Hospital-at-Home Model: Part I-Techniques and Patterns.

Hsu N, Lin Y, Tsai H, Huang T, Hsu C Diagnostics (Basel). 2025; 14(24.

PMID: 39767160 PMC: 11674558. DOI: 10.3390/diagnostics14242799.


A Review on Risk Factors, Traditional Diagnostic Techniques, and Biomarkers for Pneumonia Prognostication and Management in Diabetic Patients.

Anwar S, Alhumaydhi F, Rahmani A, Kumar V, Alrumaihi F Diseases. 2024; 12(12.

PMID: 39727640 PMC: 11726889. DOI: 10.3390/diseases12120310.


Candent issues in pneumonia. Reflections from the Fifth Annual Meeting of Spanish Experts 2023.

Rodriguez-Leal C, Gonzalez-Corralejo C, Candel F, Salavert M Rev Esp Quimioter. 2024; 37(3):221-251.

PMID: 38436606 PMC: 11094633. DOI: 10.37201/req/018.2024.

References
1.
Jasti H, Mortensen E, Obrosky D, Kapoor W, Fine M . Causes and risk factors for rehospitalization of patients hospitalized with community-acquired pneumonia. Clin Infect Dis. 2008; 46(4):550-6. DOI: 10.1086/526526. View

2.
Ospina-Tascon G, Calderon-Tapia L, Garcia A, Zarama V, Gomez-Alvarez F, Alvarez-Saa T . Effect of High-Flow Oxygen Therapy vs Conventional Oxygen Therapy on Invasive Mechanical Ventilation and Clinical Recovery in Patients With Severe COVID-19: A Randomized Clinical Trial. JAMA. 2021; 326(21):2161-2171. PMC: 8652598. DOI: 10.1001/jama.2021.20714. View

3.
Regalado de Los Cobos J, Aizpuru Barandiaran F, Oceja Barrutieta E, de Juan Rodriguez M, Apraiz Ruiz L, Altuna Basurto E . [Efficacy of hospital at home (HaH) in the treatment of community-acquired pneumonia (CAP) with different degrees of severity]. Med Clin (Barc). 2010; 135(2):47-51. DOI: 10.1016/j.medcli.2009.12.021. View

4.
Hanson K, Azar M, Banerjee R, Chou A, Colgrove R, Ginocchio C . Molecular Testing for Acute Respiratory Tract Infections: Clinical and Diagnostic Recommendations From the IDSA's Diagnostics Committee. Clin Infect Dis. 2020; 71(10):2744-2751. PMC: 7454374. DOI: 10.1093/cid/ciaa508. View

5.
Blum C, Nigro N, Briel M, Schuetz P, Ullmer E, Suter-Widmer I . Adjunct prednisone therapy for patients with community-acquired pneumonia: a multicentre, double-blind, randomised, placebo-controlled trial. Lancet. 2015; 385(9977):1511-8. DOI: 10.1016/S0140-6736(14)62447-8. View